Drug Development

Position & Issues

• • Food and Drug Administration and Drug Review
  • Representation of Older Patients in Clinical Trials

Related Publications

• Alliance Views
  Increased Funding Critical to FDA'a Success
  
  Winter 2006
  Related topics: Drug Development  Health  Policy  
  
  
  As the nation's foremost consumer protection agency, the U.S. Food and Drug Administration, (FDA) serves a critical role, safeguarding not only prescription and non-prescription drugs, but also medical devices, dietary supplements, animal drugs and feeds, and the nation's food supply.
• Science in the Spotlight
  All Roads Lead to...Sardinia!?
  
  Spring 2004
  Related topics: Diabetes  Drug Development  Health  
  
  
  A drug now in clinical trials for treatment of type 2 diabetes could eventually be used to promote longevity by treating or preventing major age-related diseases.
• Testimony
  Statement by Alliance for Aging Research Senior Director Debbie Zeldow before the Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committe Meeting, concerning Eli Lilly and Company's bone formation drug, Forteo
  
  July 27, 2001
  Related topics: Drug Development  Health  Osteoporosis  
  
  
  My name is Deborah Zeldow, and I am the Senior Director of the Alliance for Aging Research. Thank you for the opportunity to come before this committee today to address the promising findings of Forteo™ (teriparatide, Lilly), Eli Lilly and Company's bone formation drug.

More Related Publications »